Westgeest, Hans M <br/><br/>
Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry.  [electronic resource] 

 -  European urology focus  09 2018 
 - 694-701 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2405-4569 
<br/><br/><label>Standard No.: </label>10.1016/j.euf.2016.09.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Disease-Free Survival<br/>Docetaxel--administration & dosage<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis--pathology<br/>Netherlands--epidemiology<br/>Pragmatic Clinical Trials as Topic--methods<br/>Prostatic Neoplasms--drug therapy<br/>Prostatic Neoplasms, Castration-Resistant--drug therapy<br/>Registries<br/>Retrospective Studies<br/>Treatment Outcome<br/>Tubulin Modulators--therapeutic use